Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 28, 2005; 11(36): 5688-5690
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5688
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5688
Table 1 Other malignacies in patients with IPMN
| Previous | At diagnosis | Post diagnosis | Total | |
| Gastric cancer | 4 | 7 | 1 | 12 |
| Colonic cancer | 4 | 3 | 0 | 7 |
| Esophageal cancer | 3 | 1 | 0 | 4 |
| Pulmonary cancer | 0 | 2 | 2 | 4 |
| Pancreatic cancer | 0 | 2 | 1 | 3 |
| Breast cancer | 2 | 0 | 0 | 2 |
| Hepatocellular cancer | 0 | 2 | 0 | 2 |
| Uterine cancer | 1 | 0 | 0 | 1 |
| Pharyngeal cancer | 1 | 0 | 0 | 1 |
| Bile duct cancer | 0 | 1 | 0 | 1 |
| Prostatic cancer | 0 | 1 | 0 | 1 |
| Laryngeal cancer | 0 | 0 | 1 | 1 |
| Malignant lymphoma | 0 | 0 | 1 | 1 |
Table 2 Other malignancies of more than two organs in patients with IPMN
| Case | Age (yr) | Sex | Previous | At diagnosis | Postdiagnosis |
| 1 | 76 | M | Gastric cancer (EMR, 1 yr ago) | Pulmonary cancer (4 yr after) | |
| Esophageal cancer (EMR, 1 yr ago) | |||||
| 2 | 74 | F | Uterine cancer (ope, 10 yr ago) | Hepatocellular cancer | |
| Colonic cancer | |||||
| 3 | 70 | M | Gastric cancer | ||
| Colonic cancer | |||||
| Pulmonary cancer | |||||
| 4 | 83 | F | Esophageal cancer | Malignant lymphoma (1 yr after) | |
| 5 | 78 | M | Hepatocellular cancer | Gastric cancer (6 yr after) | |
| 6 | 78 | M | Esophageal cancer (EMR, 1 yr ago) | Laryngeal cancer (6 yr after) | |
| 7 | 68 | M | Esophageal cancer (EMR, 2 yr ago) | Pancreatic cancer (3 yr after) |
Table 3 Clinicopathological findings of IPMN patients with and with-out other malignancies
| With other malignancies (n = 28) | Without other malignancies (n = 51) | P | |
| Age (yr) | 71.9±8.2 | 66.8±9.3 | P<0.05 |
| Male/Female | 8/20 | 34/17 | NS |
| Follow-up period1 | 3.2±0.5 | 3.4±0.5 | NS |
| Site of IPMN | NS | ||
| Main duct | 13 | 17 | |
| Branch duct | 15 | 34 | |
| Resection/Nonresection of IPMN | 7/20 | 16/35 | NS |
| Cause of death | |||
| Invasive IPMN | 1 | 4 | |
| Gastric cancer | 4 | 0 | |
| Pulmonary cancer | 3 | 0 | |
| Pancreatic cancer | 2 | 0 | |
| Colonic cancer | 2 | 0 | |
| Esophageal cancer | 1 | 0 | |
| Hepatocellular cancer | 1 | 0 | |
| Malignant lymphoma | 1 | 0 | |
| Pneumonia | 1 | 1 | |
| Renal failure | 0 | 1 |
Table 4 IPMN concomitant with independent pancreatic cancer
| Case | Age (yr) | Sex | Syn/Met | Othermalignancies | IPMNlocation | Site | Therapy | Pancreaticlocation | Cancertherapy | Stage | Prognosis |
| 1 | 71 | M | Syn | None | Head | Branch | None | Body | DP | III | Died 7 mo after operation |
| 2 | 75 | M | Syn | None | Head | Branch | None | Head | None | IV | Died 8 mo after diagnosis |
| 31 | 68 | M | Met | Esophageal cancer | Head | Branch | PD | Head | PD | II | Alive now 3 yr after diagnosis of IPMN |
- Citation: Kamisawa T, Tu Y, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol 2005; 11(36): 5688-5690
- URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5688.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5688